Oxford Cannabinoid Names Clarissa Sowemimo-Coker As Permanent CEO

By Elena Vardon

Oxford Cannabinoid Technologies Holdings PLC on Wednesday confirmed the permanent appointment of Clarissa Sowemimo-Coker as its chief executive officer.

Ms. Sowemimo-Coker had been interim CEO of the pharmaceutical company–which is focused on developing cannabinoid-based prescription medicines–since December, when John Lucas stepped down from the role to pursue other business interests.

The group also said the U.K. government Home Office license for its subsidiary, Oxford Cannabinoid Technologies Ltd., has been renewed for the fifth consecutive year. The license allows it to possess and supply certain 1 drugs for research purposes, it said.

Write to Elena Vardon at elena.vardon@wsj.com

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *